Sorrento therapeutics, inc. (SRNE)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
ASSETS
Current assets:
Cash and cash equivalents

21,897

22,521

34,649

61,385

90,971

158,738

135,441

46,784

24,252

20,429

38,323

53,681

33,919

82,398

66,480

98,179

20,813

39,038

59,067

51,699

60,501

71,902

44,269

50,155

29,949

31,667

6,429

5,754

9,638

5,091

6,445

7,625

2,443

3,466

2,270

2,922

5,277

Restricted cash

-

13,098

9,592

9,592

9,600

9,592

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivables, net

10,023

14,454

-

-

-

3,833

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Marketable securities

-

-

94

316

391

-

297

323

-

441

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Marketable securities

-

-

-

-

-

-

-

-

444

-

888

656

1,265

1,106

1,241

34,946

46,183

97,366

64,386

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivables, net

-

-

11,560

9,786

7,409

-

2,278

2,204

3,912

2,211

1,693

2,376

2,338

1,696

526

867

1,146

903

622

898

784

732

986

576

657

394

-

-

-

-

-

-

-

-

-

-

-

Inventory

3,038

3,362

4,335

6,631

4,568

2,898

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income tax receivable

-

-

216

303

193

526

424

433

1,771

1,715

1,525

1,468

1,299

1,289

1,927

1,715

1,715

1,715

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Notes receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

600

10,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Grants receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

36

92

134

79

86

88

72

61

32

81

246

Prepaid expenses and other

14,674

14,153

7,122

5,493

5,455

3,977

6,805

5,002

6,190

4,904

2,279

2,414

3,272

3,165

1,062

556

1,875

1,996

731

1,210

879

1,281

586

705

626

571

407

75

688

80

66

13

22

29

41

4

29

Total current assets

49,632

67,588

67,568

93,506

118,579

179,564

145,245

54,746

36,569

29,700

44,708

60,595

42,093

89,654

71,836

146,263

71,732

141,018

124,806

53,807

62,164

73,915

45,841

51,436

31,232

32,632

6,873

5,922

10,461

5,251

6,598

7,727

2,538

3,557

2,344

3,008

5,553

Property and equipment, net

28,470

29,888

30,338

30,829

28,900

24,384

21,467

19,893

19,494

19,345

18,969

18,044

16,958

12,707

10,083

9,203

7,436

7,246

3,813

2,824

2,540

2,277

2,360

2,349

2,359

2,440

1,661

1,449

1,549

1,480

1,270

1,167

1,163

988

927

849

95

Operating lease right-of-use assets

46,329

46,384

47,799

46,686

43,292

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Intangibles, net

62,316

63,308

64,299

64,825

65,817

66,283

69,133

69,690

70,352

71,013

71,675

72,330

57,469

64,766

3,579

3,690

3,801

3,912

4,023

4,135

30,390

4,357

31,563

32,149

32,735

33,321

28,994

88

90

-

-

-

-

-

-

-

-

Goodwill

38,300

38,300

38,300

38,300

38,300

38,300

38,298

38,298

38,298

38,298

38,298

38,298

36,903

41,548

20,626

20,626

20,626

20,626

20,626

12,470

24,041

24,041

24,041

24,041

24,041

24,041

-

-

-

-

-

-

-

-

-

-

-

Cost method investments

237,008

237,008

-

-

-

237,008

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost method investments

-

-

237,008

237,008

237,000

-

237,008

237,008

-

237,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost method investments

-

-

-

-

-

-

-

-

237,008

-

237,008

112,008

112,008

112,008

112,008

112,008

112,008

112,008

111,500

-

-

10,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Equity method investments

24,676

25,233

25,240

25,509

27,083

27,980

29,073

29,972

32,077

32,999

34,666

79,944

76,046

76,994

59,413

59,090

57,620

58,119

60,000

21,500

11,500

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

45,050

45,150

45,150

45,150

45,150

45,000

45,000

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term assets held for sale

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

37,478

-

26,619

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other, net

4,774

4,775

5,175

5,232

5,347

5,570

2,740

2,914

3,081

3,250

3,440

3,549

3,751

3,909

1,513

524

556

590

527

602

622

332

324

345

248

148

452

328

97

48

22

22

22

22

38

38

38

Total assets

536,553

557,632

560,875

587,043

609,474

624,087

587,964

452,521

436,879

431,613

448,764

384,768

345,228

401,586

279,058

351,404

273,779

343,519

325,295

132,816

131,257

141,541

104,129

110,320

90,615

92,582

37,982

7,788

12,198

6,781

7,891

8,917

3,724

4,568

3,310

3,895

5,687

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable

28,986

27,630

26,750

24,886

14,652

13,817

17,203

9,941

9,014

9,911

12,984

9,641

11,607

8,282

1,377

4,423

3,139

1,339

1,619

2,474

1,886

1,656

1,489

1,267

1,174

2,153

1,407

735

707

439

394

276

199

224

236

202

181

Accrued payroll and related benefits

15,507

15,914

14,665

12,500

10,159

10,236

8,168

6,671

4,504

4,485

4,158

3,254

5,001

3,565

2,834

1,491

1,040

2,361

1,683

1,418

957

1,825

1,157

-

-

1,664

-

-

-

-

-

-

-

-

-

-

-

Accrued payroll and related

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,608

790

-

808

293

180

77

87

72

81

88

66

54

54

Current portion of deferred compensation

-

-

-

-

-

-

-

-

-

-

0

0

-

1,012

984

944

917

891

973

947

942

1,893

975

951

927

904

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses

14,241

18,728

18,478

17,383

23,590

13,403

12,938

4,226

8,832

7,274

4,441

6,148

4,158

4,741

4,474

37,102

6,382

3,927

3,215

909

1,082

867

1,428

476

674

385

102

162

111

66

61

67

39

46

168

167

167

Current portion of deferred revenue

3,777

3,643

3,613

3,350

3,157

2,703

632

1,878

-

3,864

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of deferred revenue

-

-

-

-

-

-

-

-

2,496

-

14,666

9,666

9,666

9,666

9,186

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

200

Derivative liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

5,520

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of deferred rent

-

-

-

-

-

-

309

243

251

212

13

14

-

248

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisition consideration payable

398

908

11,312

11,312

11,312

11,312

14,929

14,929

24,833

53,209

44,682

50,560

41,401

48,362

12,000

12,000

12,000

12,000

13,855

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of derivative liabilities

7,280

8,800

9,000

7,900

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of debt

16,585

36,261

25,877

32,257

8,678

10,150

28,231

1,511

1,594

0

2,407

0

0

209

5,188

5,067

4,949

4,835

4,722

4,613

4,537

3,316

3,655

2,608

1,686

374

-

291

267

-

-

-

-

-

-

-

-

Current portion of operating lease liabilities

3,374

3,322

3,018

2,401

2,534

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total current liabilities

90,148

115,206

112,713

111,989

74,082

61,621

82,410

39,399

51,524

78,955

83,351

79,283

71,833

76,085

36,043

61,027

28,427

30,873

26,067

10,361

9,404

9,557

8,704

6,910

5,251

5,480

2,318

1,483

1,265

584

544

415

319

359

471

425

603

Long-term debt, net of discount

182,958

199,088

234,370

223,589

229,662

223,136

145,535

16,203

5,501

5,211

24,575

26,541

26,083

47,107

458

1,801

3,113

4,394

5,646

6,868

7,656

8,830

8,446

9,442

10,317

4,431

4,785

535

608

-

-

-

-

-

-

-

-

Deferred tax liabilities, net

8,893

9,043

-

-

-

9,416

-

-

-

15,535

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax liabilities, net

-

-

8,634

8,923

9,230

-

12,472

13,281

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

114,085

114,389

114,783

115,192

115,501

116,274

118,127

118,247

-

119,287

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Derivative liabilities

36,600

35,000

29,500

19,900

14,501

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities

52,094

52,111

53,378

52,043

47,628

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term liabilities

549

39

-

-

-

6,140

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

12

12

12

877

851

796

796

1,639

1,591

1,543

1,497

-

-

-

-

-

-

-

-

-

-

-

Deferred rent and other

-

-

828

791

757

-

5,860

5,926

-

6,015

-

-

-

-

-

-

-

-

-

-

-

-

-

-

81

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax liabilities

-

-

-

-

-

-

-

-

14,640

-

105,659

48,150

48,764

53,238

35,047

35,047

35,047

49,341

34,507

1,633

12,368

1,709

14,248

14,248

14,248

14,248

-

-

-

-

-

-

-

-

-

-

-

Long-term liabilities held for sale

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

10,714

-

10,837

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

118,367

-

127,133

129,545

131,960

134,376

127,612

110,875

110,888

110,900

110,912

-

-

1,024

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent and other

-

-

-

-

-

-

-

-

5,974

-

5,757

5,053

4,482

4,278

7,404

7,414

7,329

7,061

501

-

-

75

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue, rent and other

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

11,135

1,033

-

-

-

-

117

-

-

-

-

-

-

-

-

-

-

-

Total liabilities

485,327

524,876

554,206

532,427

491,361

416,587

364,404

193,056

196,006

225,003

346,475

288,572

283,122

315,084

206,564

216,176

184,816

202,581

178,510

41,562

-

32,828

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent and other

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

102

105

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued other

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

25

-

-

-

-

-

-

-

-

-

-

-

-

Commitments and contingencies (See Note 10)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Equity:
Sorrento Therapeutics, Inc. equity
Preferred stock, $0.0001 par value; 100,000,000 shares authorized and no shares issued or outstanding

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Common stock, $0.0001 par value 750,000,000 shares authorized and 204,566,004 and 167,798,120 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

23

18

13

13

13

13

13

12

10

9

9

9

6

6

26

7

4

4

4

4

4

4

3

3

2

2

1

1

33

1

29

29

26

26

24

24

25

Additional paid-in capital

875,712

788,122

692,473

665,515

657,115

626,658

588,938

574,316

480,691

413,901

357,898

353,162

304,610

303,865

336,594

336,952

189,839

184,898

181,652

180,164

177,952

176,227

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accumulated other comprehensive loss

-215

-270

-129

48

100

15

79

153

352

242

123

218

-56

-118

328

25,454

36,690

73,579

54,386

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock subscription receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

43,502

43,502

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Additional paid-in capital

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

130,000

129,429

102,102

99,668

52,442

23,977

23,763

17,146

16,512

16,425

10,389

10,288

8,156

8,086

7,927

Accumulated deficit

-725,013

-659,818

-596,998

-532,583

-475,821

-367,750

-317,974

-270,646

-196,784

-165,120

-213,565

-211,503

-197,316

-174,252

-162,299

-176,668

-131,719

-113,329

-89,853

-88,914

-77,956

-67,518

-59,013

-

-

-32,861

-

-

-

-

-

-

-

-

-

-

-

Treasury stock, 7,568,182 shares at cost at March 31, 2020, and December 31, 2019

49,464

49,464

49,464

49,464

49,464

49,464

49,464

49,464

49,464

49,464

49,464

49,464

49,464

49,464

51,491

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deficit accumulated during the development stage

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

51,408

42,954

-

21,565

18,209

13,472

10,950

9,195

7,954

7,011

6,104

5,342

4,640

2,868

Total Sorrento Therapeutics, Inc. stockholders’ equity

101,043

78,588

45,895

83,529

131,943

209,472

221,592

254,371

234,805

199,568

95,001

92,422

57,780

80,037

79,656

142,243

94,814

145,152

146,189

91,254

100,000

108,713

70,990

78,024

59,150

66,809

30,878

5,769

10,324

6,197

7,347

8,501

3,404

4,209

2,838

3,470

5,083

Noncontrolling interests

-49,817

-45,832

-39,226

-28,913

-13,830

-1,972

1,968

5,094

6,068

7,042

7,288

3,774

4,326

6,465

-7,162

-7,015

-5,851

-4,214

596

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total equity

51,226

32,756

6,669

54,616

118,113

207,500

223,560

259,465

240,873

206,610

102,289

96,196

62,106

86,502

72,494

135,228

88,963

140,938

146,785

-

-

108,713

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total liabilities and stockholders’ equity

536,553

557,632

560,875

587,043

609,474

624,087

587,964

452,521

436,879

431,613

448,764

384,768

345,228

401,586

279,058

351,404

273,779

343,519

325,295

132,816

131,257

141,541

104,129

110,320

90,615

92,582

37,982

7,788

12,198

6,781

7,891

8,917

3,724

4,568

3,310

3,895

5,687